Publications by authors named "Vivek Mediratta"
Article Synopsis
- There is a significant prevalence of liver injury (LI) among patients hospitalized with COVID-19, but large-scale studies on risk factors and outcomes are limited.
- The study assessed adult COVID-19 patients to determine the frequency of liver enzyme abnormalities, classifying them into mild elevation (MEL) and liver injury (LI) groups compared to a control group with normal liver enzymes.
- Findings revealed that patients with LI faced notably higher risks of mortality, ICU admission, intubation, and longer hospital stays compared to those without liver enzyme issues.
